Breaking News

You are here » Indian-Commodity  :  Commodities  :  Gold Rates Sink On Friday As Greenback Gets Back

14-May2011

Gold Rates Sink On Friday As Greenback Gets Back

Gold costs got an unpleasant blow on the previous exchanging period of week and wrecked close to a per cent level on back of come back in American dollar, producing the yellow-colored metal much less attractive to members of other money. The wilt in yellow-colored metal rates have also been on the back of anticipation there wasn't any basis for Fed to think about QE3 because along with the completed of 2nd round of quantitative reducing in June, the year-on-year overall inflation was standing at 3.2%, that is consistent with anticipation.

Gold commodity for June supply stepped $13.10 to stay at $1,493.60 an oz after dealing as tall as $1,516.40 and as lower as $1,482 on the Comex section of NYME , whereas the spot yellow metal rates drop $11.7 to stay at $1,495.20 an oz.

Related News

View all news

BT Cotton Seeds Businesses Targeting Earnings Of Rs 700 Crore This Season

BT Cotton seeds organizations are targeting earnings of Rs 700 cr this season as a result of a rise ......

Gold Challenges To Maintain Earlier Increases As The Problems In Europe Prolongs

Gold prices surrounded reduce on Monday because the euro solved their deficits in opposition to the ......

Copper Seems To Lengthen Uptrend As Dollar Recoils

Copper rates were able to lengthen the uptrend for 3rd instantly period on Monday, as traders proved......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......